Page 97 - EJMO-9-1

Eurasian Journal of Medicine and
Oncology
T2D polymorphisms in Asians

effects of the C1431T and Pro12Ala PPARγ gene variants Laplante M, Estall JL. PGC1A regulates the IRS1:IRS2 ratio
on plasma lipids and diabetes risk in an Asian population. during fasting to influence hepatic metabolism downstream
J Lipid Res 2004;45:674-685. of insulin. Proc Natl Acad Sci. 2019;116(10):4285-4290.
doi: 10.1194/jlr.M300363-JLR200 doi: 10.1073/pnas.1815150116
48. Wang X, Liu J, Ouyang Y, Fang M, Gao H, Liu L. The 58. Kleiner S, Mepani RJ, Laznik D, et al. Development of insulin
Association between the Pro12Ala variant in the PPARγ2 resistance in mice lacking PGC-1α in adipose tissues. Proc
Gene and type 2 diabetes mellitus and obesity in a Chinese Natl Acad Sci U S A. 2012;109(24):9635-9640.
Population. PLoS One. 2013;8(8):e71985.
doi: 10.1073/pnas.1207287109
doi: 10.1371/journal.pone.0071985
59. Bhatta P, Bermano G, Williams HC, Knott RM.
49. Hu W, Jiang C, Guan D, et al. Patient adipose stem cell-derived Genomics meta-analysis demonstrates Gly482Ser
adipocytes reveal genetic variation that predicts antidiabetic variant of PPARGC1A is associated with components of
drug response. Cell Stem Cell. 2019;24:299-308.e6. metabolic syndrome within Asian populations. Genomics.
doi: 10.1016/j.stem.2018.11.018 2020;112(2):1795-1803.
50. Soccio RE, Chen ER, Rajapurkar SR, et al. Genetic variation doi: 10.1016/j.ygeno.2019.10.011
determines PPARγ function and anti-diabetic drug response 60. Chibalin AV, Leng Y, Vieira E, et al. Downregulation of
in vivo. Cell. 2015;162(1):33-44. diacylglycerol kinase delta contributes to hyperglycemia-
doi: 10.1016/j.cell.2015.06.025 induced insulin resistance. Cell. 2008;132(3):375-386.
51. Zhou X, Wei LJ, Li JQ, et al. The Activation of peroxisome doi: 10.1016/j.cell.2007.12.035
proliferator-activated receptor γ enhances insulin signaling 61. Jiang LQ, de Castro Barbosa T, Massart J, et al. Diacylglycerol
pathways via up-regulating chemerin expression in high kinase-δ regulates AMPK signaling, lipid metabolism, and
glucose treated HTR-8/SVneo cells. Matern Fetal Med. skeletal muscle energetics. Am J Physiol Endocrinol Metab.
2020;2:131-140. 2016;310(1):E51-60.
doi: 10.1097/FM9.0000000000000044 doi: 10.1152/ajpendo.00209.2015
52. Trombetta M, Bonetti S, Boselli ML, et al. PPARG2 Pro12Ala 62. Emanuelli B, Eberlé D, Suzuki R, Kahn CR. Overexpression
and ADAMTS9 rs4607103 as ‘insulin resistance loci’ and of the dual-specificity phosphatase MKP-4/DUSP-9 protects
‘insulin secretion loci’ in Italian individuals. The GENFIEV against stress-induced insulin resistance. Proc Natl Acad Sci.
study and the Verona Newly Diagnosed Type 2 Diabetes 2008;105(9):3545-3550.
Study (VNDS) 4. Acta Diabetol. 2013;50(3):401-408.
doi: 10.1073/pnas.0712275105
doi: 10.1007/s00592-012-0443-9
63. Fukuda H, Imamura M, Tanaka Y, et al. A Single
53. Boesgaard TW, Gjesing AP, Grarup N, et al. Variant near nucleotide polymorphism within DUSP9 is associated with
ADAMTS9 known to associate with type 2 diabetes is susceptibility to type 2 diabetes in a Japanese population.
related to insulin resistance in offspring of type 2 diabetes PLoS One. 2012;7(9):e46263.
patients - EUGENE2 study. PLoS One. 2009;4(9):e7236.
doi: 10.1371/journal.pone.0046263
doi: 10.1371/journal.pone.0007236
64. Al-Daghri NM, Al-Attas OS, Krishnaswamy S, et al.
54. Graae AS, Grarup N, Ribel-Madsen R, et al. ADAMTS9 Association of type 2 diabetes mellitus related SNP genotypes
regulates skeletal muscle insulin sensitivity through with altered serum adipokine levels and metabolic syndrome
extracellular matrix alterations. Diabetes. 2019;68(3):502-514. phenotypes. Int J Clin Exp Med. 2015;8:4464-4471.
doi: 10.2337/db18-0418 65. Perelis M, Ramsey KM, Marcheva B, Bass J. Circadian
55. Yang M, Ren Y, Lin Z, et al. Krüppel-like factor 14 increases transcription from beta cell function to diabetes
insulin sensitivity through activation of PI3K/Akt signal pathophysiology. J Biol Rhythms. 2016;31(4):323-336.
pathway. Cell Signal. 2015;27(11):2201-2208. doi: 10.1177/0748730416656949
doi: 10.1016/j.cellsig.2015.07.019 66. Peschke E, Bähr I, Mühlbauer E. Melatonin and pancreatic
56. Small KS, Todorčević M, Civelek M, et al. Regulatory islets: Interrelationships between melatonin, insulin and
variants at KLF14 influence type 2 diabetes risk via a female- glucagon. Int J Mol Sci. 2013;14(4):6981-7015.
specific effect on adipocyte size and body composition. Nat doi: 10.3390/ijms14046981
Genet. 2018;50(9):1342.
67. Tuomi T, Nagorny CLF, Singh P, et al. Increased melatonin
doi: 10.1038/s41588-018-0180-2
signaling is a risk factor for type 2 diabetes. Cell Metab.
57. Besse-Patin A, Jeromson S, Levesque-Damphousse P, Secco B, 2016;23(6):1067-1077.

Volume 9 Issue 1 (2025) 89 doi: 10.36922/ejmo.7549